Last reviewed · How we verify
Hydrochlorthiazide and Amiloride — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Hydrochlorthiazide and Amiloride (Hydrochlorthiazide and Amiloride) — University of Cambridge.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Hydrochlorthiazide and Amiloride TARGET | Hydrochlorthiazide and Amiloride | University of Cambridge | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Hydrochlorthiazide and Amiloride CI watch — RSS
- Hydrochlorthiazide and Amiloride CI watch — Atom
- Hydrochlorthiazide and Amiloride CI watch — JSON
- Hydrochlorthiazide and Amiloride alone — RSS
Cite this brief
Drug Landscape (2026). Hydrochlorthiazide and Amiloride — Competitive Intelligence Brief. https://druglandscape.com/ci/hydrochlorthiazide-and-amiloride. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab